| Date Filed | Type | Description |
| 08/08/2023 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 12,000 options to buy
@ $2.08, valued at
$25k
|
|
| 12/08/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 10/17/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 32,056 options to buy
@ $2.08, valued at
$66.7k
Exercised 27,676 options to buy
@ $2.08, valued at
$57.6k
|
|
| 05/03/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $2.08, valued at
$41.6k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 01/12/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 7,485 shares
@ $52.4574, valued at
$392.6k
Sold 10,673 shares
@ $53.3476, valued at
$569.4k
Sold 4,201 shares
@ $54.4026, valued at
$228.5k
Sold 106 shares
@ $54.99, valued at
$5.8k
Sold 9,932 shares
@ $53.6759, valued at
$533.1k
Sold 6,644 shares
@ $54.4224, valued at
$361.6k
Sold 347 shares
@ $55.0529, valued at
$19.1k
Sold 2,726 shares
@ $51.3122, valued at
$139.9k
Sold 4,022 shares
@ $52.0163, valued at
$209.2k
Sold 1,623 shares
@ $53.27, valued at
$86.5k
Sold 241 shares
@ $53.97, valued at
$13k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 375,000 options to buy
@ $48.46, valued at
$18.2M
|
|
| 08/21/2020 |
4
| Mainolfi Nello (President and CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 125,399 options to buy
@ $20, valued at
$2.5M
|
|
| 08/20/2020 |
3
| Mainolfi Nello (President and CEO) has filed a Form 3 on Kymera Therapeutics, Inc. |